Hsbc Holdings PLC A Tyr Pharma Inc Call Options Transaction History
Hsbc Holdings PLC
- $176 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LIFE
# of Institutions
135Shares Held
48.5MCall Options Held
4.03MPut Options Held
4.43M-
Federated Hermes, Inc. Pittsburgh, PA10.5MShares$19.6 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.63MShares$10.5 Million0.0% of portfolio
-
Ubs Group Ag4.51MShares$8.38 Million0.0% of portfolio
-
State Street Corp Boston, MA4.2MShares$7.8 Million0.0% of portfolio
-
Octagon Capital Advisors LP New York, NY3.82MShares$7.11 Million2.7% of portfolio
About aTYR PHARMA INC
- Ticker LIFE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,625,000
- Market Cap $53.2M
- Description
- aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...